Business Description
AREV Life Sciences Global Corp
NAICS : 325412
SIC : 3741
ISIN : CA04019J1093
Description
AREV Life Sciences Global Corp is a fully integrated, early stage life science discovery enterprise dedicated to delivering solutions to public healthcare metrics through innovations and successful collaborations in the life science industry. The Company's focuses on dedication to generate revenue by way of novel therapeutic approaches to human nutrition and malnutrition, pandemic diseases, and neglected chronic co-morbidities.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.01 | |||||
| Equity-to-Asset | -5.46 | |||||
| Debt-to-Equity | -0.13 | |||||
| Debt-to-EBITDA | -0.88 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | -127.17 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -55 | |||||
| 3-Year EBITDA Growth Rate | 49.5 | |||||
| 3-Year EPS without NRI Growth Rate | 48.1 | |||||
| 3-Year FCF Growth Rate | 31.3 | |||||
| 3-Year Book Growth Rate | 18.8 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 100 | |||||
| 9-Day RSI | 99.96 | |||||
| 14-Day RSI | 99.41 | |||||
| 6-1 Month Momentum % | 4900 | |||||
| 12-1 Month Momentum % | -90.42 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.05 | |||||
| Quick Ratio | 0.05 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -49.4 | |||||
| Shareholder Yield % | -1.16 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -3014.29 | |||||
| Net Margin % | -3414.29 | |||||
| FCF Margin % | -2880 | |||||
| ROA % | -89.58 | |||||
| ROIC % | -80.05 | |||||
| ROC (Joel Greenblatt) % | -132.32 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 45 | |||||
| EV-to-EBIT | -12.23 | |||||
| EV-to-EBITDA | -17.42 | |||||
| EV-to-Revenue | 410.57 | |||||
| EV-to-FCF | -14.74 | |||||
| Earnings Yield (Greenblatt) % | -8.18 | |||||
| FCF Yield % | -6.87 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:AREVF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
AREV Life Sciences Global Corp Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0.005 | ||
| EPS (TTM) ($) | -0.011 | ||
| Beta | 5.49 | ||
| Volatility % | 1171.9 | ||
| 14-Day RSI | 99.41 | ||
| 14-Day ATR ($) | 0.004796 | ||
| 20-Day SMA ($) | 0.0385 | ||
| 12-1 Month Momentum % | -90.42 | ||
| 52-Week Range ($) | 0.0002 - 0.11868 | ||
| Shares Outstanding (Mil) | 31.76 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
AREV Life Sciences Global Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
AREV Life Sciences Global Corp Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
AREV Life Sciences Global Corp Frequently Asked Questions
What is AREV Life Sciences Global Corp(AREVF)'s stock price today?
The current price of AREVF is $0.11. The 52 week high of AREVF is $0.12 and 52 week low is $0.00.
When is next earnings date of AREV Life Sciences Global Corp(AREVF)?
The next earnings date of AREV Life Sciences Global Corp(AREVF) is .
Does AREV Life Sciences Global Corp(AREVF) pay dividends? If so, how much?
AREV Life Sciences Global Corp(AREVF) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers